Yae Kanai

Scopus著者プロファイル

ウェブサイトhttps://k-ris.keio.ac.jp/html/100002171_ja.html

h-index

年別の研究成果

フィンガープリント

Yae Kanaiが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。

1 類似のプロファイル

283 Article
19 Review article
9 Letter
3 Chapter
その他

Efficacy and safety findings of the EXTRA study in older adult EGFR-mutant lung cancer patients receiving afatinib as first-line treatment
Morikawa, K., Takata, S., Tanaka, H., Itani, H., Ishihara, M., Horiuchi, K., Kato, Y., Ikemura, S., Nakagawa, H., Nakahara, Y., Seki, Y., Bessho, A., Takahashi, N., Hayashi, K., Endoh, T., Takeyama, K., Maekura, T., Takigawa, N., Kawase, A. & Endoh, M. & 11 others, Nemoto, K., Kishi, K., Soejima, K., Okuma, Y., Yoshimura, K., Saigusa, D., Kanai, Y., Ueda, K., Togashi, A., Matsutani, N. & Seki, N., 2026 12月, In: Scientific reports. 16, 1, 8316.
研究成果: Article › 査読

Open Access
Genome-wide DNA methylation profiling of pleomorphic carcinoma of the lung
Nakagomi, T., Fujimoto, M., Kuriyama, S., Hishida, T., Asamura, H., Asakura, K., Kanai, Y. & Arai, E., 2026 1月, In: Human Pathology. 167, 106001.
研究成果: Article › 査読

Open Access
1 リンクは新しいタブで開きます被引用数 (Scopus)
Prognostically Significant Glycan Profiles of Clear Cell Renal Cell Carcinoma Identified by Integrated Glycome–Methylome Analysis
Kitazume, Y., Arai, E., Fujimoto, M., Ohara, K., Matsuda, A., Kakuda, S., Fujimoto, H., Maeshima, A. M., Hiraoka, N., Yoshida, T., Kuno, A. & Kanai, Y., 2026 1月, In: Pathology International. 76, 1, e70070.
研究成果: Article › 査読

Open Access
1 リンクは新しいタブで開きます被引用数 (Scopus)
Celecoxib prevents malignant progression of smoking-induced lung tumors via suppression of the COX-2/PGE₂ signaling pathway in mice
Sakurai, K., Chubachi, S., Miyata, J., Hamamoto, J., Naganuma, T., Shimada, T., Otake, S., Nakayama, S., Irie, H., Tsutsumi, A., Kameyama, N., Hegab, A. E., Shimoda, M., Terai, H., Yasuda, H., Kanai, Y., Arita, M. & Fukunaga, K., 2025, In: Frontiers in Immunology. 16, 1557790.
研究成果: Article › 査読

Open Access
9 リンクは新しいタブで開きます被引用数 (Scopus)
Classification based on tumor phenotypes enables the novel molecular characterization of esophagogastric junction cancer
Takahashi, K., Hatakeyama, K., Terashima, M., Nagashima, T., Urakami, K., Ohshima, K., Ochiai, A., Shimoda, T., Koseki, Y., Furukawa, K., Fujiya, K., Tanizawa, Y., Tsubosa, Y., Bando, E., Kanai, Y., Akiyama, Y. & Yamaguchi, K., 2025 11月, In: Gastric Cancer. 28, 6, p. 1114-1124 11 p.
研究成果: Article › 査読

金井弥栄

フィンガープリント

過去5年の共同研究と上位研究分野

詳細を開く

Efficacy and safety findings of the EXTRA study in older adult EGFR-mutant lung cancer patients receiving afatinib as first-line treatment

Genome-wide DNA methylation profiling of pleomorphic carcinoma of the lung

Prognostically Significant Glycan Profiles of Clear Cell Renal Cell Carcinoma Identified by Integrated Glycome–Methylome Analysis

Celecoxib prevents malignant progression of smoking-induced lung tumors via suppression of the COX-2/PGE₂ signaling pathway in mice

Classification based on tumor phenotypes enables the novel molecular characterization of esophagogastric junction cancer

金井 弥栄

フィンガープリント

過去5年の共同研究と上位研究分野

研究成果

Efficacy and safety findings of the EXTRA study in older adult EGFR-mutant lung cancer patients receiving afatinib as first-line treatment

Genome-wide DNA methylation profiling of pleomorphic carcinoma of the lung

Prognostically Significant Glycan Profiles of Clear Cell Renal Cell Carcinoma Identified by Integrated Glycome–Methylome Analysis

Celecoxib prevents malignant progression of smoking-induced lung tumors via suppression of the COX-2/PGE2 signaling pathway in mice

Classification based on tumor phenotypes enables the novel molecular characterization of esophagogastric junction cancer

金井弥栄

Celecoxib prevents malignant progression of smoking-induced lung tumors via suppression of the COX-2/PGE₂ signaling pathway in mice